Osteogenesis Imperfecta Clinical Trial at OHSU 

The purpose of the study is to learn about the effects of the study drug, Setrusumab, to find the best dose for treating OI type I, III, or IV and to see how well the study drug is tolerated. Lodging and travel for the research participant and one travel companion are provided through the study.